Nigel McNelly
Opus Corporate Finance
Bioquell plc
Deal Type
Unknown
Sector
Healthcare
Completion Date
6th April 2016
Deal Value
£42m
Company Background
Bioquell PLC designs, manufactures, and supplies bio-decontamination and containment equipment, and related products and services to the pharmaceutical, healthcare, food, and defense industries in the United Kingdom and internationally. Its bio-decontamination solutions include hydrogen peroxide vapour bio-decontamination equipment and services for the life sciences, healthcare, and defense sectors; chemical, biological, radiological, and nuclear filtration systems and environmental control equipment for military vehicles and fixed facilities; and professional services, including room bio-decontamination services.
Deal Summary
Advised Bioquell (a healthcare decontamination business) on a return of capital by way of a tender offer.
Bioquell plc deal contacts
Key members of the Opus Corporate Finance deal team crucial in the Bioquell plc transaction
Latest Mergers Alliance News
Khronos Advisory (Thailand) has advised Electricity Generating Public Company Limited (EGCO) on USD95 million capital increase in PT Chandra Daya Investasi
Dresner Partners (USA) advised Connoisseurs Products on its sale to Willert Home Products
Ethica Group (Italy) advised Vicenza Mode, high-end knitwear manufacturer, in the sale of a majority stake to Sienna PE
